VERRICA PHARMACEUTICALS INC

$3.91 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About VERRICA PHARMACEUTICALS INC

Verrica Pharmaceuticals Inc. is a dermatology therapeutics company. The Company is focused on developing and commercializing treatments for skin diseases. The Company's lead product candidate, VP-102, is a drug-device combination of its topical solution of cantharidin, a widely recognized, naturally sourced agent to treat topical dermatological conditions, administered through its single-use precision applicator. It is developing VP-102 for the treatment of molluscum contagiosum (molluscum), a highly contagious and primarily pediatric viral skin disease, external genital warts and common warts. It also intends to develop its second cantharidin-based product candidate, VP-103, for the treatment of plantar warts, which are warts located on the bottom of the foot. It also intends to develop its third product candidate, LTX-315, for the treatment of dermatological oncology indications, including non-metastatic melanoma and non-metastatic Merkel cell carcinoma.

Stock Analysis

last close $4.04
1-mo return 18.8%
3-mo return -25.5%
avg daily vol. 166.26T
52-week high 14.79
52-week low 1.77
market cap. $166M
forward pe -
annual div. -
roe -97.7%
ltg forecast -
dividend yield -
annual rev. $0M
inst own. 26.6%
baraka

Subscribe now for daily local and international financial news

Subscribe